AUXL: Summary for Auxilium Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, December 16, 2009, 3:28pm EST - Canadian Markets close in 32 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Auxilium Pharmaceuticals Inc. (AUXL)

At 15:13 EST: 30.80 USD

1.70 (5.23%)

MORE ON AUXL

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Auxilium Pharmaceuticals, Inc. (NasdaqNM:AUXL) Delayed quote data

Last Trade:	30.80 USD
Trade Time:	3:13PM EST
Change:	1.70 (5.23%)
Prev Close:	32.50
Open:	31.26
Bid:	30.79 x 400
Ask:	30.80 x 100
1y Target Est:	32.20

Day's Range:	30.08 - 31.75
52wk Range:	19.33 - 37.28
Volume:	2,862,144
Avg Vol (3m):	430,783
Market Cap:	1.45B
P/E (ttm):	N/A
EPS (ttm):	-1.13
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add AUXL to Portfolio

Download Data

HEADLINES

•	Auxilium shares fall on Xiaflex study results
	AP (Wed 12:43pm)

•	Auxilium Shares Gettin' Shafted
	at CNBC (Wed 11:53am)

•	UPDATE - Auxilium penis drug trial yields mixed results
	at Reuters (Wed 11:14am)

•	Auxilium reports positive mid-stage study results
	AP (Wed 10:13am)

•	InPlay: Auxilium Pharma announces top line Ph IIb XIAFLEX Peyronie's results
	Briefing.com (Wed 7:01am)

•	AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exh
	EDGAR Online (Wed 7:01am)

•	Auxilium Announces Top Line Phase IIb XIAFLEX(TM) Peyronie's Results
	Marketwire (Wed 7:00am)

•	Setback for Endo Pharma
	Zacks.com (Fri, Dec 11)

•	[video] Collagen Disease Breakthrough
	at TheStreet.com (Mon, Nov 16)

•	AUXILIUM PHARMACEUTICALS INC Financials
	EDGAR Online Financials (Wed, Nov 11)

•	Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
	Marketwire (Wed, Nov 11)

•	Auxilium Pharmaceuticals to Present at the Credit Suisse 18th Annual Global Healthcare Conference
	Marketwire (Tue, Nov 10)

More Headlines for AUXL...

ANALYST

EPS Est (next year) (Dec-07) :	N/A
EPS Est (in 2 years) (Dec-08) :	N/A
Avg Rec (current)*:	2.2
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing and marketing products to urologists, endocrinologists, orthopedists, and select primary care physicians primarily in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•